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| INTRODUCTION
Fibrinogen, a glycoprotein with coagulation function, is synthesized by the liver. It is converted into soluble fibrin by thrombin and finally converted into a stable insoluble fibrin clot after cross-linking with Factor XIII a and Ca 2+ . 1, 2 Fibrinogen, a ligand for platelet glycoprotein II b /III a , is involved in platelet aggregation. 3 Congenital fibrinogen deficiencies include quantitative deficiencies (afibrinogenemia and hypofibrinogenemia) and qualitative deficiencies (dysfibrinogenemia and hypodysfibrinogenemia) of fibrinogen. 4 Congenital dysfibrinogenemia, a hereditary disease that causes dysfunctional fibrinogen, is caused by mutation in one of the fibrinogen genes. There is significant heterogeneity in the clinical manifestations of this disease, most patients being asymptomatic. Approximately 25% of patients experience bleeding, 20% have thrombosis, and some have both a bleeding tendency and thrombosis. 5 Most asymptomatic patients are identified by routine coagulation tests, the diagnostic findings being an obviously prolonged thrombin time with normal or slightly prolonged prothrombin time (PT) and activated partial thromboplastin time.
The PT-derived method shows normal fibrinogen concentrations, whereas the Clauss method shows remarkably decreased fibrinogen activity. [6] [7] [8] Quantitation of fibrinogen concentrations is an important screening tool for coagulation disorders, with screening methods comprising physical, chemical, immunological, and coagulable protein methods. The Clauss and PT-derived methods are both coagulable protein methods. Many recent studies have focused on the Clauss and PT-derived methods for quantitating fibrinogen concentrations, mainly in the general population or in patients receiving anticoagulant therapy. [9] [10] [11] In this study, we measured plasma fibrinogen concentrations in 73 patients with congenital dysfibrinogenemia and 81 normal controls by the Clauss, PT-derived, and immunological methods, compared their results. Receiver operating characteristic (ROC) curves were used to evaluate the value of fibrinogen PT-derived/Clauss ratio for screening for congenital dysfibrinogenemia.
| MATERIALS AND METHODS
This study was approved by the Ethics Committee of our institution and informed consent was obtained from all participants.
| Plasma of normal controls
Plasma was collected from 81 healthy controls who were undergoing health checks. They comprised 31 male and 50 female persons aged 7-81 years (mean 39.5 years). Their results of coagulation were normal. The PT-derived method resulted in fibrinogen concentrations of 2-5 g/L. Liver, kidney, heart, and lung function were normal. The controls included no menstruating or pregnant women. 
| Plasma of patients with congenital dysfibrinogenemia

| Specimen preparation
Plasma was obtained from venous blood drawn in the morning from fasting participants and anticoagulated by adding 0.109 mol/L sodium citrate in a 1:9 ratio. All specimens were centrifuged at 1006.2 × g for 10 minutes to produce platelet-poor plasma, which was assessed within 2 hours.
| Analysis of plasma specimens
Coagulation of sodium citrate-anticoagulated whole blood was detected with an ACL TOP-700 Automated Coagulation Analyzer (Instrumentation Laboratory, Milan, Italy) and the required reagents. and the optimal critical point of diagnosis was obtained by analyzing every point in the ROC curve to determine sensitivity and specificity.
| Statistical analysis
A value of P < .05 was considered to denote statistical significance.
| RESULTS
| Comparison of fibrinogen concentrations quantitated by the Clauss, PT-derived, and ELISA methods
According to the Clauss method, fibrinogen concentrations were significantly lower in patients with congenital dysfibrinogenemia than in normal controls, whereas the fibrinogen PT-derived/Clauss ratio showed them to be significantly higher. Intragroup comparison of the Clauss and PT-derived methods showed that fibrinogen concentrations were significantly lower in patients with congenital dysfibrinogenemia when measured by the Clauss method. However, in normal controls, fibrinogen concentrations were slightly lower when measured by the Clauss method. Results of the Clauss and PT-derived methods were both in the normal range. All the above differences were statistically significant (P < .05; Table 1 ).
The mean fibrinogen antigen measured by ELISA in normal controls was 3.89 ± 0.57 g/L and showed slightly higher values than measured by the Clauss method, nevertheless, no significant difference was found when comparing to the PT-derived method. In patients with congenital dysfibrinogenemia, the mean fibrinogen antigen measured by ELISA was 3.64 ± 0.68 g/L, similar to the mean fibrinogen concentration measured by the PT-derived method, and functional fibrinogen values measured by Clauss were markedly lower.
| Analysis of correlation between fibrinogen concentrations quantitated by the Clauss, PT-derived, and ELISA methods
There was a good correlation between fibrinogen concentrations determined by the Clauss and PT-derived methods in normal controls (r = .900, P < .001; Figure 1A ). However, there was a poor correlation in fibrinogen concentrations measured by each method in patients with congenital dysfibrinogenemia (r = .522, P < .001; Figure 1B ).
Fibrinogen concentrations determined by the Clauss method correlated well with ELISA in normal controls (r = .871, P < .001; Figure 2A ).
However, there was a poor correlation between these two methods in patients with congenital dysfibrinogenemia (r = .454, P < .001; Figure 2B ).
Fibrinogen concentrations determined by the PT-derived method had a good correlation with ELISA in both normal controls (r = .923, P < .001; Figure 3A ) and in patients with congenital dysfibrinogenemia (r = .898, P < .001; Figure 3B ).
| ROC curves for the diagnosis of congenital dysfibrinogenemia using the fibrinogen PT-derived/ Clauss ratio
The area under the ROC curve was 1 with a standard error of 0, 95% confidence interval of 0.976-1.000, and optimal critical diagnostic point of 1.43. When the fibrinogen PT-derived/Clauss ratio was >1.43, the sensitivity and specificity for diagnosis of congenital dysfibrinogenemia were both 100% (Figure 4 ). In contrast, the PT-derived method is an indirect mean of determining fibrinogen concentrations. The principle of this method is as follows: during determination of PT, fibrinogen is converted into fibrin; the turbidity of plasma is proportional to fibrinogen concentrations, which are calculated by an endpoint or rate method. 9, 15 This method is not only rapid, simple, and economical, but also has some limitations.
| DISCUSSION
The PT-derived method can be used to calculate fibrinogen concentrations based on changes in plasma turbidity. Therefore, jaundice, hemolysis, lipidemia, and other factors that interfere with transparency can influence the results of the PT-derived method. A previous study 16 If only the Clauss method is used in patients with congenital dysfibrinogenemia, the condition can easily be misdiagnosed as hypofibrinogenemia, whereas if only the PT-derived method or immunoturbidimetry is utilized, fibrinogen concentrations appear normal or slightly high, easily resulting in missed diagnoses. 18 Thus, both the Clauss and PT-derived methods should be employed to determine fibrinogen concentrations when attempting to diagnose congenital dysfibrinogenemia. But a few fibrinogen variants, such as fibrin Longmont, should be noted. Functional fibrinogen concentrations were determined by an electromechanical Clauss assay and antigen levels analyzed by rocket immunoelectrophoresis were both within the normal range. 19 Further study of fibrin Longmont demonstrated that protofibril formation was normal, nevertheless, the lateral aggregation of protofibrils was impaired and then resulting in abnormal fibrin polymerization. 20 As far as we know, the clot formation can be determined by mechanical or optical techniques. Clot detection by mechanical endpoint techniques depends on the tensile strength of the clot formation; optical systems depend on the change in turbidity resulting from the formation of fibrin fibers clot. 12 In such variant, the normal formation of protofibril showed similar rate of protofibril growth as well as the final protofibril size to normal fibrinogen. 21 So, it may be the explanation of fibrin Longmont showed normal functional and immunologic fibrinogen levels.
Immunological assays provide accuracy results of fibrinogen concentrations; however, sources of errors must be taken into account, for example, intact and various types of degraded fibrinogen molecules can be identified by specific monoclonal antibodies that falsely cause overestimation of fibrinogen antigen levels. 22 In the present study, fibrinogen concentrations measured by ELISA showed similar results to the PT-derived method and correlated well both in normal controls and in patients with congenital dysfibrinogenemia. This suggested that PT-derived method provide diagnostic values similar to the ELISA method.
Normal fibrinogen antigen and significantly decreased fibrinogen activity are important features of coagulation in patients with dysfibrinogenemia. 23 , 24 Peyvandi 25 reported that the fibrinogen antigen/ activity ratio is usually higher than 2:1 in patients with dysfibrinogenemia; however, the sensitivity and specificity for diagnosis of this disease are unknown. The PT-derived method rapidly provides fibrinogen concentrations with no extra cost, and fibrinogen concentrations measured by the PT-derived method were corresponding to antigen levels in this study. So, fibrinogen PT-derived/Clauss ratio was calculated for each participant. The ratio of 81 normal controls was 1.11 ± 0.11, whereas in 73 patients with congenital dysfibrinogenemia, the fibrinogen PT-derived/Clauss ratio being 6.24 ± 1.43.
ROC curve analysis demonstrated that the area under the ROC curve was 1 with a standard error of 0 and 95% confidence interval of 0.976-1.00, indicating that diagnosis of congenital dysfibrinogenemia based on the fibrinogen PT-derived/Clauss ratio is extremely accurate. When the fibrinogen PT-derived/Clauss ratio was >1.43, the sensitivity and specificity for diagnosis of congenital dysfibrinogenemia were both 100%. We therefore concluded that the fibrinogen PT-derived/Clauss ratio is an important screening tool for congenital dysfibrinogenemia.
This study compared fibrinogen concentrations measured by the Clauss, PT-derived and ELISA methods in normal controls and in patients with congenital dysfibrinogenemia, evaluated the accuracy of the fibrinogen PT-derived/Clauss ratio for diagnosis of congenital dysfibrinogenemia using ROC curves for the first time to the best of our knowledge, and calculate the sensitivity and specificity when the ratio F I G U R E 3 Scatterplot of fibrinogen concentrations measured by the PT-derived method and ELISA in normal controls (A) and in patients with congenital dysfibrinogenemia (B)
Receiver operating characteristic (ROC) curves for the diagnosis of congenital dysfibrinogenemia using the fibrinogen PTderived/Clauss ratio is at the optimal critical point. Nevertheless, this study also has some limitations including the relatively small number of cases, which may have introduced some bias.
In summary, the clinical manifestations of congenital dysfibrinogenemia are heterogeneous and most patients are asymptomatic.
Laboratory examination is the key to diagnosing congenital dysfibrinogenemia. If the Clauss or PT-derived methods used alone to measure fibrinogen concentrations, congenital dysfibrinogenemia may easily be misdiagnosed or missed. Thus, it is necessary to determine fibrinogen concentrations by both the Clauss and PT-derived methods. ROC curves revealed that diagnosing congenital dysfibrinogenemia using the fibrinogen PT-derived/Clauss ratio is extremely accurate; thus, the ratio could serve as a critical screening tool for diagnosing congenital dysfibrinogenemia.
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